2023 World Conference on Lung Cancer (Posters)-P1.18. Systematic Enrolment Ensures High Participation Rate in Lung Cancer Screening - Results of Regional Pilot Study in Estonia

P1.18. Systematic Enrolment Ensures High Participation Rate in Lung Cancer Screening - Results of Regional Pilot Study in Estonia - PDF(Slides)

Back to course

Pdf Summary

A regional pilot study in Estonia aimed to assess the feasibility and effectiveness of systematic enrollment of participants for lung cancer screening (LCS) in the target age group of 55-74 years. In 74 family physician practices, a total of 137,181 patients were listed, with 26,759 of them in the target age group. Family physicians and nurses attempted to reach 91.2% of the target age group, evaluating their LCS inclusion-exclusion criteria through phone or outpatient visits. The enrollment ensured a high uptake rate of 79.3% in the target group. The screening results, including lung cancer cases and incidental findings, were comparable to studies conducted in other countries. The study's data provides valuable information for planning a national LCS program in Estonia and other countries with similar healthcare systems. Among the exclusion criteria for the LCS target group, non-smokers, refusal to participate, lack of health insurance, recent chest CT, and other reasons were identified. In total, 28 cases of lung cancer were confirmed by June 2023, with most cases in stage I. Surgical treatment was performed in 64% of the cases. Incidental findings were detected in 96.9% of the patients, with coronary atherosclerosis and emphysema being the most common. Additionally, 12 other malignant tumors, including kidney cancer, were found. The study highlights the importance of high participation rates for effective LCS programs and suggests that systematic enrollment through family physicians or nurses can be a feasible approach.

Asset Subtitle

Tanel Laisaar

Meta Tag

Speaker Tanel Laisaar

Topic Screening & Early Detection: Recruitment & Screening Uptake

Keywords

lung cancer screening

feasibility

enrollment

uptake rate

screening results

incidental findings

exclusion criteria

surgical treatment

coronary atherosclerosis

malignant tumors